Global News Wire: Pluristem Therapeutics Forms Strategic Alliance with ChaBio & Diostech

Pluristem Therapeutics (PSTI) is a developer of placenta-based cell therapies. They have just formed a strategic alliance with Cha Bio&Diostech.

Read more »

Dimera Fights the “Silent Killer”

According to the American Heart Association, heart disease is the number one killer of women over age 25–more than the next five causes of death, or all forms of cancer, combined.

Read more »

CSI Enrolls First Patient in Study of Vascular Device

Cardiovascular Systems, a medical device company that specializes in the treatment of vascular diseases, has enrolled the first patient in its COMPLIANCE 360° clinical trial.

Read more »

Washington Company Secures $40 Million In Funding

Pathway Medical Technologies, Inc. recently announced that it has secured a $40 million Series D round of financing, reports DeviceSpace. Raising such a large amount of capital is a rare achievement for a medical device venture, particularly in today’s tough economic climate.

Read more »